HOME >> MEDICINE >> NEWS
World's first approval of new HIV drug TMC114 provides potent new treatment option with FUZEON

UZEON. This is likely to be driven by the unique mechanism of action of FUZEON and the activity of TMC114 against PI-resistant virus", commented Dr Anton Pozniak, the Chelsea and Westminster Hospital, London.

"We welcome Tibotec's launch of TMC114 and realize just how important an opportunity this is for patients facing HIV resistance who are in need of new options. With the compelling data and approval of TMC114 physicians can now aggressively pursue undetectable viral load and give their patients the best possible care," commented Jenny Edge-Dallas, Roche's newly appointed head of HIV.


'"/>

Contact: Alexander Watson
alexander.watson@ketchum.com
44-207-611-3663
Ketchum
23-Jun-2006


Page: 1 2

Related medicine news :

1. Worlds largest respiratory health study launches next phase
2. Worlds largest clinical trial into rare bone cancer well underway conference hears
3. Worlds largest osteoporosis congress closes; significant studies released
4. Worlds largest osteoporosis congress opens in Toronto
5. Worlds pledge to halve hunger by 2015 looks like empty promise
6. Worlds poorest children missing out on child survival strategies
7. RAND presents first Victor Fuchs Research Award to economists at Carnegie Mellon University
8. Worcester Polytechnic Institute to host national forum on locating first responders inside buildings
9. Screening for behavioral health first step to getting treatment
10. Polish journalist scoops first prize in prestigious European award
11. Poker match pits an vs. machine in world first match

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, ... Elite. The attorneys chosen by their peers for this recognition are considered among the ... Traurig Shareholders received special honors as members of this year’s Legal Elite Hall of ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 26, 2016 One of ... has announced the formation of a new biotechnology company, Noxopharm Limited ... $6m in an IPO and to list on the ASX. ... candidate, NOX66, ready to enter a Phase 1 clinical study later ... designed to address one of the biggest problems facing cancer patients ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology:
Cached News: